DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Blackstein M, Vogel CL, Ambinder R. et al.
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.
Oncology 2002; 62: 2-8
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.